263 related articles for article (PubMed ID: 24038213)
1. Tolterodine activates the prefrontal cortex during bladder filling in OAB patients: a real-time NIRS-urodynamics study.
Sakakibara ; Tateno F; Yano M; Takahashi O; Sugiyama M; Ogata T; Kishi M; Tsuyusaki Y; Yamamoto T; Uchiyama T; Yamanishi T; Shibata C
Neurourol Urodyn; 2014 Sep; 33(7):1110-5. PubMed ID: 24038213
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an experimental urodynamic platform to identify treatment effects: a randomized, placebo-controlled, crossover study in patients with overactive bladder.
Frenkl T; Railkar R; Shore N; Bailen J; Sutherland S; Burke J; Scott BB; Ruddy M; Beals C
Neurourol Urodyn; 2012 Jan; 31(1):69-74. PubMed ID: 21905086
[TBL] [Abstract][Full Text] [Related]
3. Tolterodine for the treatment of urge urinary incontinence.
Elterman DS; Chughtai B; Kaplan SA; Barkin J
Expert Opin Pharmacother; 2013 Oct; 14(14):1987-91. PubMed ID: 23885788
[TBL] [Abstract][Full Text] [Related]
4. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
Malone-Lee JG; Al-Buheissi S
BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
[TBL] [Abstract][Full Text] [Related]
5. Clinical and urodynamic effects of tolterodine in women with an overactive bladder.
Wang CL; Wu CH; Liu CM; Shen CJ; Lin KL; Long CY
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):381-4. PubMed ID: 24075377
[TBL] [Abstract][Full Text] [Related]
6. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
[TBL] [Abstract][Full Text] [Related]
7. Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats.
Hedlund P; Streng T; Lee T; Andersson KE
J Urol; 2007 Jul; 178(1):326-31. PubMed ID: 17507042
[TBL] [Abstract][Full Text] [Related]
8. Effects on bladder function of combining elocalcitol and tolterodine in rats with outflow obstruction.
Streng T; Andersson KE; Hedlund P; Gratzke C; Baroni E; D'Ambrosio D; Benigni F
BJU Int; 2012 Jul; 110(2 Pt 2):E125-31. PubMed ID: 22288904
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fesoterodine and tolterodine in patients with overactive bladder.
Chapple CR; Van Kerrebroeck PE; Jünemann KP; Wang JT; Brodsky M
BJU Int; 2008 Nov; 102(9):1128-32. PubMed ID: 18647298
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
DuBeau CE; Morrow JD; Kraus SR; Creanga D; Bavendam T
Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
Ginsberg D; Schneider T; Kelleher C; Van Kerrebroeck P; Swift S; Creanga D; Martire DL
BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
[TBL] [Abstract][Full Text] [Related]
13. Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.
Gillespie JI; Palea S; Guilloteau V; Guerard M; Lluel P; Korstanje C
BJU Int; 2012 Jul; 110(2 Pt 2):E132-42. PubMed ID: 22734512
[TBL] [Abstract][Full Text] [Related]
14. Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
Coyne KS; Elinoff V; Gordon DA; Deng DY; Brodsky M; Glasser DB; Jumadilova Z; Carlsson M
Int J Clin Pract; 2008 Jun; 62(6):925-31. PubMed ID: 18479285
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder.
Anderson RU; MacDiarmid S; Kell S; Barada JH; Serels S; Goldberg RP
Int Urogynecol J Pelvic Floor Dysfunct; 2006 Sep; 17(5):502-11. PubMed ID: 16724169
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of tolterodine extended release in male and female patients with overactive bladder.
Dmochowski R; Abrams P; Marschall-Kehrel D; Wang JT; Guan Z
Eur Urol; 2007 Apr; 51(4):1054-64; discussion 1064. PubMed ID: 17097217
[TBL] [Abstract][Full Text] [Related]
17. Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER.
Zinner N; Noe L; Rasouliyan L; Marshall T; Seifeldin R
Curr Med Res Opin; 2008 Jun; 24(6):1583-91. PubMed ID: 18423103
[TBL] [Abstract][Full Text] [Related]
18. Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder.
Rovner ES; Rackley R; Nitti VW; Wang JT; Guan Z;
Urology; 2008 Sep; 72(3):488-93. PubMed ID: 18639327
[TBL] [Abstract][Full Text] [Related]
19. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
Kaiho Y; Nishiguchi J; Kwon DD; Chancellor MB; Arai Y; Snyder PB; Yoshimura N
BJU Int; 2008 Mar; 101(5):615-20. PubMed ID: 18070178
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.
Herschorn S; Swift S; Guan Z; Carlsson M; Morrow JD; Brodsky M; Gong J
BJU Int; 2010 Jan; 105(1):58-66. PubMed ID: 20132103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
